论文部分内容阅读
目的:对埃索美拉唑治疗消化性溃疡的安全性以及效果进行分析和探讨。方法:选择我院在2013年12月-2014年5月收治的70例确诊为消化性溃疡患者作为研究对象,以不同的治疗方式为根据,将患者分为对照组以及观察组,每组患者各有35例,采用奥美拉唑联合抗生素的方式针对对照组患者进行治疗,采用埃索美拉唑针对观察组患者进行治疗,对两组患者对临床疗效进行对比和分析。结果:观察组35例患者中治愈的28例,有效6例,无效1例,总有效率97.14%,对照组35例患者中治愈的21例,有效7例,无效7例,总有效率80%的,两组患者相比差异显著具有统计学意义(P<0.05)。结论:在针对消化性溃疡患者进行治疗的时候采用埃索美拉唑具有十分明显的治疗效果,可以较快地缓解患者的症状,还具有十分轻微的不良反应,因此是对消化性溃疡进行治疗的比较理想的药物,值得在临床上推广和应用。
Objective: To analyze the safety and efficacy of esomeprazole in the treatment of peptic ulcer. Methods: Seventy patients with peptic ulcer diagnosed in our hospital from December 2013 to May 2014 were selected as research objects. Based on different treatment methods, patients were divided into control group and observation group, and each group of patients Each with 35 cases. The patients in the control group were treated with the combination of omeprazole and antibiotics. The patients in the observation group were treated with esomeprazole. The clinical efficacy of the two groups were compared and analyzed. Results: Among the 35 patients in the observation group, 28 were cured, 6 were effective, 1 was ineffective and the total effective rate was 97.14%. Among 35 patients in the control group, 21 were cured, 7 were effective, 7 were ineffective and the total effective rate was 80 %, The difference between the two groups was statistically significant (P <0.05). Conclusions: The use of esomeprazole in the treatment of patients with peptic ulcer has a very significant therapeutic effect, which can relieve the patient’s symptoms more quickly and has very mild side effects and therefore is a treatment for peptic ulcer The more ideal medicine, it is worth to promote and apply in clinic.